Jasper Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · Redwood City, CA, United States
- PrincipalsHerb CrossChief Financial OfficerJeetinder Singh MahalCEO and PresidentRon MartellPresident, CEO and Director
- CompanyJasper Therapeutics, Inc.Redwood City, CA, United States
- Phone line+1 (650) 549-1400General business
Jasper Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker JSPR) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 3
Finance
Herb CrossChief Financial Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Jeetinder Singh Mahal — CEO and President
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Herb Cross — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Ron Martell — President, CEO and Director
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Pl. VIICrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityPl. VIIDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityPl. VIIJazz Pharmaceuticals plcPharmaceutical Preparations · Dublin1 shared capabilityPl. VIIAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityPl. VIIEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPl. VIIenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityPl. VIIPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityPl. VIIEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capability